Article Information
History
- June 26, 2024.
Article Versions
- You are currently viewing Version 1 of this article (June 26, 2024 - 14:19).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Andrea Szydlo-Shein1,
- Blanca Sanz-Magallón Duque de Estrada1,
- Joshua Rosenheim1,
- Carolin T. Turner1,
- Evdokia Tsaliki1,
- Marc C. I. Lipman2,3,
- Heinke Kunst4,5,
- Gabriele Pollara1,
- Philip M. Elks6,
- Jean-Pierre Levraud7,
- Elspeth M. Payne8,
- Mahdad Noursadeghi1 and
- Gillian S. Tomlinson1,*
- 1Division of Infection and Immunity, University College London, London, UK
- 2Respiratory Medicine, Royal Free London NHS Foundation Trust, London, UK
- 3UCL Respiratory, University College London, London, UK
- 4Barts Health NHS Trust, London, UK
- 5Blizard Institute, Queen Mary University of London, London, UK
- 6The Bateson Centre, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK
- 7Université Paris-Saclay, CNRS UMR9197, Institut Pasteur, Université Paris-Cité, Institut des Neurosciences Paris-Saclay, 91400 Saclay, France
- 8Research Department of Haematology, Cancer Institute, University College London, London, UK
- ↵*Corresponding author: Gillian S. Tomlinson, Email: g.tomlinson{at}ucl.ac.uk
Posted June 26, 2024.
Type I interferon responses contribute to immune protection against mycobacterial infection
